AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in AbCellera Biologics Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +8 vs. Q3 2021
- Shares held
- 114.5M
- +15.8M (+16.0%) vs. Q3 2021
- Total value
- $1.63B
- −$348.9M (−17.6%) vs. Q3 2021
- New holders
- 33
- 43 more added
- Sold out
- 25
- 30 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABCL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $908.8M |
| Q1 2026 | 138 | $434.0M |
| Q4 2025 | 144 | $370.6M |
| Q3 2025 | 141 | $524.6M |
| Q2 2025 | 128 | $370.6M |
| Q1 2025 | 129 | $280.1M |
| Q4 2024 | 146 | $333.9M |
| Q3 2024 | 139 | $274.6M |
| Q2 2024 | 148 | $338.3M |
| Q1 2024 | 154 | $547.4M |
| Q4 2023 | 143 | $681.1M |
| Q3 2023 | 138 | $551.8M |
| Q2 2023 | 170 | $809.1M |
| Q1 2023 | 183 | $980.7M |
| Q4 2022 | 203 | $1.30B |
| Q3 2022 | 190 | $1.21B |
| Q2 2022 | 162 | $1.26B |
| Q1 2022 | 130 | $1.10B |
| Q4 2021 | 124 | $1.63B |
| Q3 2021 | 116 | $1.98B |
| Q2 2021 | 114 | $1.99B |
| Q1 2021 | 86 | $2.42B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding AbCellera Biologics Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 539,203 | $7.71M | 0.01% | +454,903+539.6% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 659,750 | $9.43M | 0.34% | 00.0% | Unchanged |
| Woodline Partners LP | 670,639 | $9.59M | 0.14% | +273,823+69.0% | Added |
| Millennium Management LLC | 696,361 | $9.96M | 0.01% | −151,458−17.9% | Reduced |
| Federated Hermes, Inc. | 827,847 | $11.8M | 0.02% | +237,847+40.3% | Added |
| Royal Bank of Canada | 844,362 | $12.1M | 0.00% | +657,862+352.7% | Added |
| Capital International Inc | 929,578 | $13.3M | 0.12% | −21,576−2.3% | Reduced |
| Intellectus Partners, LLC | 1,192,379 | $17.1M | 4.35% | −31,050−2.5% | Reduced |
| Alyeska Investment Group, L.P. | 1,417,363 | $20.3M | 0.23% | +1,345,543+1,873.5% | Added |
| Swedbank AB | 1,951,940 | $28.0M | 0.05% | +146,930+8.1% | Added |
| Parametric Portfolio Associates LLC | 2,000,000 | $28.6M | 0.01% | +300,000+17.6% | Added |
| BlackRock Inc. | 2,367,242 | $33.9M | 0.00% | +1,390,655+142.4% | Added |
| Credit Suisse AG | 2,622,325 | $37.5M | 0.03% | −180,086−6.4% | Reduced |
| Guardian Capital Advisors LP | 3,836,414 | $45.3M | 4.36% | 00.0% | Unchanged |
| Baillie Gifford & Co | 3,573,908 | $51.1M | 0.03% | +333,365+10.3% | Added |
| Founders Fund VII Management, LLC | 3,773,530 | $54.0M | 89.75% | 00.0% | Unchanged |
| Harvard Management Co Inc | 4,105,095 | $58.7M | 5.51% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,180,768 | $59.8M | 0.78% | 00.0% | Unchanged |
| DCVC Bio GP, LLC | 7,305,761 | $104.5M | 100.00% | +7,305,761 | New |
| Capital International Investors | 8,131,951 | $116.3M | 0.02% | +1,022,062+14.4% | Added |
| SB Management Ltd | 9,817,190 | $140.4M | 13.97% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 10,450,180 | $149.4M | 0.73% | 00.0% | Unchanged |
| Allianz Asset Management GmbH | 11,165,010 | $159.7M | 0.12% | −693,786−5.9% | Reduced |
| Capital World Investors | 22,051,703 | $315.3M | 0.05% | +2,230,296+11.3% | Added |
| Clough Capital Partners L P | 0 | $0 | 0.00% | −971,297−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −338,120−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −331,414−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −272,984−100.0% | Sold out |
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −246,907−100.0% | Sold out |
| Pendal Group Limited | 0 | $0 | 0.00% | −64,826−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −57,540−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −54,345−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −49,165−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −28,613−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −28,110−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Myriad Asset Management Ltd. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −15,121−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −12,282−100.0% | Sold out |
| United Capital Financial Advisers, LLC | 0 | $0 | 0.00% | −10,650−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −6,888−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Evolution Wealth Advisors, LLC | 0 | $0 | 0.00% | −415−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −52−100.0% | Sold out |